Home > Riviste > Chirurgia > Fascicoli precedenti > Chirurgia 2021 October;34(5) > Chirurgia 2021 October;34(5):222-6

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

CASE REPORT   

Chirurgia 2021 October;34(5):222-6

DOI: 10.23736/S0394-9508.20.05227-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Breast implant-associated anaplastic large cell lymphoma: case report and literature review

Rebecca J. FISHER 1 , Kishan P. PAREKH 1, Rebecca HARSTEN 2, Philip IDAEWOR 1, Abdalla SAAD ABDALLA AL-ZAWI 1, Wayne CHICKEN 1

1 Department of Surgery, Basildon and Thurrock University Hospital, Basildon, UK; 2 Department of Surgery, Royal London Hospital, London, UK



The number of reported cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is increasing along with attention and discussion amongst physicians. After first being described in 1997, the World Health Organization in 2016 classified BIA-ALCL as a mature T cell neoplasm. This increasing acknowledgment and awareness will help in guiding management towards appropriate diagnosis and effective treatment. BIA-ALCL is originally a T-cell lymphoma, where the malignant T-cells have a large pleomorphic and anaplastic morphology. The immuno-histochemistry expresses immuno-reactivity to CD30. It is an anaplastic lymphoma kinase (ALK) surface receptor negative anaplastic large cell lymphoma. We present an additional case of BIA-ALCL, the presentation and management; and provide an overview of the literature related to this condition.


KEY WORDS: Lymphoma, large-cell, anaplastic; T-lymphocytes, cytotoxic; Breast implants

inizio pagina